Abstract
Novel compounds of biological interest were synthesized by in situ reduction of Schiff’s base of 5,6-dimethoxy indanone and 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one in the presence of Ti(OiPr)4 and NaBH3CN. Further alkylation using different alkyl/aryl halides in the presence of NaH in DMF gave a series of novel compounds. A formation of newly synthesized compounds was confirmed on the basis of their spectral and elemental analysis. Further these compounds were screened for their antimicrobial activity and found to have promising antibacterial and antifungal activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barreca ML, Rao A, Luca LD, Iraci N, Monforte AM, Maga G, Clercq ED, Pannecouque C, Balzarini J, Chimirri A (2007) Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains. Bioorg Med Chem Lett 17:1956–1960
Haadsma-Svensson SR, Cleek KA, Dinh DM, Duncan JN, Haber CL, Huff RM, Lajiness ME, Nichols NF, Smith MW, Svensson KA (2001) Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans. J Med Chem 44:4716–4732
Ito F, Kondo H, Noguchi H, Ohashi Y, Yamagishi T (2000) 4-(2-keto-1-benzimidazolinyl) piperidine compounds as ORL1-receptor agonists. US 6423725
Kawamoto H, Ozaki S, Itoh Y, Miyaji M, Arai S, Nakashima H, Kato T, Ohta H, Iwasawa Y (1999) Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397). J Med Chem 42:5061
Khodarahmi G, Chen C, Hakimelahi G, Tseng C, Chern J (2005) Design, synthesis, and cytotoxicity of 4-sulfonamide substituted benzamidobenzimidazolones and an acyl benzimidazolone. J Iran Chem Soc 2:124–134
Kleemann A, Engel J, Kutscher B, Reichert D (1999) Pharmaceutical substances. Thieme, New York
Liang R, Parmee Emma R (2006) Glucagon receptor antagonist compounds, composition containing such compounds and method of use. WO/2006/104826
Lynch JK, Collins CA, Freeman JC, Gao J, Iyengar RR, Judd AS, Kym PR, Mulhern MM, Sham HL, Souers AJ (2005), Antagonist of Melanin concentrating hormoneeffects on the Melanin concentrating receptor. US20050209274
Mavrova AT, Anichina KK, Vuchev DI, Tsenov JA, Kondeva MS, Micheva MK (2005) Synthesis and antitrichinellosis activity of some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones. Bioorg Med Chem 13:5550–5559
Messaoudi S, Sancelme M, Polard-Housset V, Aboab B, Moreau P, Prudhomme M (2004) Synthesis and biological evaluation of oxindoles and benzimidazolinones derivatives. Eur J Med Chem 39:453–458
Nacak S, Dogruer DS, Sahin MF (1999) Synthesis and antinociceptive activity of (1-benzyl-2(3H)-benzimidazolon-3-yl) acetic acid derivatives. Farmaco 54:768–772
Raymond A, Stokbroekx et al. (1996) 1-(4-Aryl-cyclohexyl) piperidine derivatives, method of use thereof. US4329353
Vora JJ, Patel DR, Bhimani NV, Ajudia PV (2010) Synthesis and biological evaluation of potent benzimidazolone derivatives. Der Pharma Sinica 2:178–183
Wayne J, Thomspon et al. (1998), Muscarine agonists. US5718912
Yoshinao Tsuda et al. (1978) 4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof. US4329353
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Patel, V., Bhatt, N., Bhatt, P. et al. Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one derivatives as potential antimicrobial agents. Med Chem Res 23, 2133–2139 (2014). https://doi.org/10.1007/s00044-013-0799-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0799-6